nodes	percent_of_prediction	percent_of_DWPC	metapath
Eprosartan—ABCC2—Transmembrane transport of small molecules—ATP10A—autistic disorder	0.00611	0.00611	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—OXTR—autistic disorder	0.00596	0.00596	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—HTR1D—autistic disorder	0.00592	0.00592	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—GRM8—autistic disorder	0.00551	0.00551	CbGpPWpGaD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—HTR1B—autistic disorder	0.0055	0.0055	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—IFNG—autistic disorder	0.00537	0.00537	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—WNT2—autistic disorder	0.00533	0.00533	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—OPRM1—autistic disorder	0.00531	0.00531	CbGpPWpGaD
Eprosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—MAPK1—autistic disorder	0.00527	0.00527	CbGpPWpGaD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—DRD1—autistic disorder	0.00511	0.00511	CbGpPWpGaD
Eprosartan—ABCC2—NRF2 pathway—SLC6A4—autistic disorder	0.00503	0.00503	CbGpPWpGaD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—DRD3—autistic disorder	0.00495	0.00495	CbGpPWpGaD
Eprosartan—CYP2C9—Phase 1 - Functionalization of compounds—MAOB—autistic disorder	0.00491	0.00491	CbGpPWpGaD
Eprosartan—AGTR1—G alpha (q) signalling events—AVP—autistic disorder	0.00488	0.00488	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—AVPR1A—autistic disorder	0.00485	0.00485	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—AVP—autistic disorder	0.00482	0.00482	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—IL2—autistic disorder	0.00477	0.00477	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR1B—autistic disorder	0.00471	0.00471	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—OXT—autistic disorder	0.00471	0.00471	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—GRM5—autistic disorder	0.00468	0.00468	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—OXTR—autistic disorder	0.00453	0.00453	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—SCT—autistic disorder	0.00449	0.00449	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—HTR5A—autistic disorder	0.00442	0.00442	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—DRD1—autistic disorder	0.00438	0.00438	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—autistic disorder	0.00436	0.00436	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—GABBR1—autistic disorder	0.00428	0.00428	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—ADM—autistic disorder	0.00428	0.00428	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—DRD3—autistic disorder	0.00424	0.00424	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—GSTM5—autistic disorder	0.00422	0.00422	CbGpPWpGaD
Eprosartan—CYP2C9—Metapathway biotransformation—GSTM5—autistic disorder	0.00417	0.00417	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—SLC9A9—autistic disorder	0.00413	0.00413	CbGpPWpGaD
Eprosartan—AGTR1—G alpha (q) signalling events—HTR2A—autistic disorder	0.00406	0.00406	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—OPRM1—autistic disorder	0.00404	0.00404	CbGpPWpGaD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—ADRB2—autistic disorder	0.00401	0.00401	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—HTR5A—autistic disorder	0.00401	0.00401	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—GABRG3—autistic disorder	0.00394	0.00394	CbGpPWpGaD
Eprosartan—ABCC2—NRF2 pathway—GSTP1—autistic disorder	0.0038	0.0038	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—GABBR2—autistic disorder	0.00376	0.00376	CbGpPWpGaD
Eprosartan—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP19A1—autistic disorder	0.00367	0.00367	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—autistic disorder	0.00363	0.00363	CbGpPWpGaD
Eprosartan—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—autistic disorder	0.00362	0.00362	CbGpPWpGaD
Eprosartan—CYP2C9—Arachidonic acid metabolism—PLA2G4A—autistic disorder	0.00361	0.00361	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—OXT—autistic disorder	0.00359	0.00359	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—HTR1B—autistic disorder	0.00359	0.00359	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—HTR3A—autistic disorder	0.00351	0.00351	CbGpPWpGaD
Eprosartan—ABCC2—NRF2 pathway—GSTM1—autistic disorder	0.00349	0.00349	CbGpPWpGaD
Eprosartan—CYP2C9—Arachidonic acid metabolism—GPX1—autistic disorder	0.00346	0.00346	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—ADRB2—autistic disorder	0.00344	0.00344	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—GABBR2—autistic disorder	0.00341	0.00341	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—HTR1D—autistic disorder	0.00335	0.00335	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—DRD1—autistic disorder	0.00334	0.00334	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—DRD3—autistic disorder	0.00323	0.00323	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—AVP—autistic disorder	0.00323	0.00323	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—POMC—autistic disorder	0.0032	0.0032	CbGpPWpGaD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—HTR2A—autistic disorder	0.00314	0.00314	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CALCA—autistic disorder	0.00312	0.00312	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—GRM8—autistic disorder	0.00311	0.00311	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—HTR1D—autistic disorder	0.00304	0.00304	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—GABRA5—autistic disorder	0.00299	0.00299	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—GABRA4—autistic disorder	0.00299	0.00299	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—GABRB1—autistic disorder	0.00299	0.00299	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—SLC40A1—autistic disorder	0.00299	0.00299	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—GABRA3—autistic disorder	0.00299	0.00299	CbGpPWpGaD
Eprosartan—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—autistic disorder	0.00298	0.00298	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—PDE4A—autistic disorder	0.00293	0.00293	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—GABRB3—autistic disorder	0.00286	0.00286	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—GABRA1—autistic disorder	0.00286	0.00286	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—GRM8—autistic disorder	0.00283	0.00283	CbGpPWpGaD
Eprosartan—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—autistic disorder	0.00275	0.00275	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—AVPR1A—autistic disorder	0.00274	0.00274	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—WNT2—autistic disorder	0.00274	0.00274	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—autistic disorder	0.00269	0.00269	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—PDE4A—autistic disorder	0.00266	0.00266	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—GRM5—autistic disorder	0.00265	0.00265	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—VIP—autistic disorder	0.00265	0.00265	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—ADRB2—autistic disorder	0.00262	0.00262	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—MAOB—autistic disorder	0.00261	0.00261	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—OXTR—autistic disorder	0.00256	0.00256	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—GABRB2—autistic disorder	0.00254	0.00254	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—GABRA2—autistic disorder	0.00254	0.00254	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—SCT—autistic disorder	0.00254	0.00254	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—AVPR1A—autistic disorder	0.00249	0.00249	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NRP2—autistic disorder	0.00247	0.00247	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—AVP—autistic disorder	0.00246	0.00246	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—ADM—autistic disorder	0.00242	0.00242	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—GABBR1—autistic disorder	0.00242	0.00242	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—VIP—autistic disorder	0.0024	0.0024	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—GRM5—autistic disorder	0.0024	0.0024	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—HTR5A—autistic disorder	0.00237	0.00237	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—PDE4B—autistic disorder	0.00236	0.00236	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—OXTR—autistic disorder	0.00233	0.00233	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—SCT—autistic disorder	0.0023	0.0023	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—OPRM1—autistic disorder	0.00228	0.00228	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—SLC1A3—autistic disorder	0.00226	0.00226	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—AQP4—autistic disorder	0.00226	0.00226	CbGpPWpGaD
Eprosartan—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—autistic disorder	0.00221	0.00221	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—GABBR1—autistic disorder	0.0022	0.0022	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—ADM—autistic disorder	0.0022	0.0022	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—POMC—autistic disorder	0.00215	0.00215	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—PDE4B—autistic disorder	0.00214	0.00214	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—OPRM1—autistic disorder	0.00207	0.00207	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—HTR2A—autistic disorder	0.00205	0.00205	CbGpPWpGaD
Eprosartan—CYP2C9—Arachidonic acid metabolism—PTGS2—autistic disorder	0.00204	0.00204	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—HTR1B—autistic disorder	0.00203	0.00203	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—OXT—autistic disorder	0.00203	0.00203	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—CP—autistic disorder	0.00202	0.00202	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—GABBR2—autistic disorder	0.00201	0.00201	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—DHCR7—autistic disorder	0.00201	0.00201	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—DRD1—autistic disorder	0.00189	0.00189	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—HTR1B—autistic disorder	0.00184	0.00184	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—OXT—autistic disorder	0.00184	0.00184	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—DRD3—autistic disorder	0.00183	0.00183	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—HTR1D—autistic disorder	0.0018	0.0018	CbGpPWpGaD
Eprosartan—CYP2C9—Phase 1 - Functionalization of compounds—POMC—autistic disorder	0.00179	0.00179	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—IL5—autistic disorder	0.00179	0.00179	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CALCA—autistic disorder	0.00177	0.00177	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PRLR—autistic disorder	0.00173	0.00173	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—TF—autistic disorder	0.00171	0.00171	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—DRD1—autistic disorder	0.00171	0.00171	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—GRM8—autistic disorder	0.00167	0.00167	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—DRD3—autistic disorder	0.00166	0.00166	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—autistic disorder	0.00164	0.00164	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—POMC—autistic disorder	0.00163	0.00163	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—IL5—autistic disorder	0.00162	0.00162	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—WNT2—autistic disorder	0.00162	0.00162	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CALCA—autistic disorder	0.0016	0.0016	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—GHR—autistic disorder	0.00159	0.00159	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—CYP19A1—autistic disorder	0.00158	0.00158	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PDE4A—autistic disorder	0.00157	0.00157	CbGpPWpGaD
Eprosartan—CYP2C9—Metapathway biotransformation—CYP19A1—autistic disorder	0.00156	0.00156	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—ADRB2—autistic disorder	0.00148	0.00148	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—AVPR1A—autistic disorder	0.00147	0.00147	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—COMT—autistic disorder	0.00147	0.00147	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—GSTP1—autistic disorder	0.00146	0.00146	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—MAOA—autistic disorder	0.00146	0.00146	CbGpPWpGaD
Eprosartan—CYP2C9—Metapathway biotransformation—COMT—autistic disorder	0.00145	0.00145	CbGpPWpGaD
Eprosartan—CYP2C9—Metapathway biotransformation—GSTP1—autistic disorder	0.00144	0.00144	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—VIP—autistic disorder	0.00142	0.00142	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—GRM5—autistic disorder	0.00142	0.00142	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—AVP—autistic disorder	0.00139	0.00139	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—OXTR—autistic disorder	0.00137	0.00137	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—SCT—autistic disorder	0.00136	0.00136	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—GSTM1—autistic disorder	0.00134	0.00134	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—ADRB2—autistic disorder	0.00134	0.00134	CbGpPWpGaD
Eprosartan—CYP2C9—Metapathway biotransformation—GSTM1—autistic disorder	0.00133	0.00133	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—autistic disorder	0.00132	0.00132	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—GABBR1—autistic disorder	0.0013	0.0013	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—ADM—autistic disorder	0.0013	0.0013	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—EIF4E—autistic disorder	0.00128	0.00128	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—NPAS2—autistic disorder	0.00127	0.00127	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PDE4B—autistic disorder	0.00127	0.00127	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—AVP—autistic disorder	0.00126	0.00126	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—autistic disorder	0.00126	0.00126	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—INPP1—autistic disorder	0.00126	0.00126	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ACADSB—autistic disorder	0.00126	0.00126	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—OPRM1—autistic disorder	0.00123	0.00123	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—AVP—autistic disorder	0.00119	0.00119	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—PLA2G4A—autistic disorder	0.00119	0.00119	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—HTR2A—autistic disorder	0.00116	0.00116	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—BTD—autistic disorder	0.00112	0.00112	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—GZMB—autistic disorder	0.00112	0.00112	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—OXT—autistic disorder	0.00109	0.00109	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—HTR1B—autistic disorder	0.00109	0.00109	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—RORA—autistic disorder	0.00107	0.00107	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—HTR2A—autistic disorder	0.00105	0.00105	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—PRKCB—autistic disorder	0.00101	0.00101	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—TSC1—autistic disorder	0.00101	0.00101	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—DRD1—autistic disorder	0.00101	0.00101	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NTRK2—autistic disorder	0.000984	0.000984	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—DRD3—autistic disorder	0.00098	0.00098	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—PIK3CG—autistic disorder	0.00097	0.00097	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—IL5—autistic disorder	0.000959	0.000959	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—TDO2—autistic disorder	0.000953	0.000953	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—POMC—autistic disorder	0.00095	0.00095	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CALCA—autistic disorder	0.000947	0.000947	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—POMC—autistic disorder	0.000924	0.000924	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—PRKCB—autistic disorder	0.000921	0.000921	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—DHCR7—autistic disorder	0.000896	0.000896	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—PIK3CG—autistic disorder	0.000881	0.000881	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—EXT1—autistic disorder	0.000849	0.000849	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—SLC6A8—autistic disorder	0.000849	0.000849	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—POMC—autistic disorder	0.000839	0.000839	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PRL—autistic disorder	0.000837	0.000837	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—DAO—autistic disorder	0.00081	0.00081	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—ADRB2—autistic disorder	0.000794	0.000794	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—UPB1—autistic disorder	0.000777	0.000777	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—AVP—autistic disorder	0.000746	0.000746	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—IGF2—autistic disorder	0.000742	0.000742	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GSTM5—autistic disorder	0.000722	0.000722	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ASMT—autistic disorder	0.000722	0.000722	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PLA2G4A—autistic disorder	0.000701	0.000701	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—IL2—autistic disorder	0.000683	0.000683	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—MEF2C—autistic disorder	0.000682	0.000682	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—SLC25A12—autistic disorder	0.000679	0.000679	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—ITGB3—autistic disorder	0.000665	0.000665	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—SLC19A1—autistic disorder	0.000661	0.000661	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—HTR2A—autistic disorder	0.00062	0.00062	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—IL2—autistic disorder	0.00062	0.00062	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—autistic disorder	0.000607	0.000607	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—TSC2—autistic disorder	0.000589	0.000589	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ADSL—autistic disorder	0.000589	0.000589	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—XDH—autistic disorder	0.000577	0.000577	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—LEP—autistic disorder	0.000577	0.000577	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—APOE—autistic disorder	0.000577	0.000577	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—STX1A—autistic disorder	0.000567	0.000567	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—NPAS2—autistic disorder	0.000567	0.000567	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—TCN2—autistic disorder	0.000547	0.000547	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PRKCB—autistic disorder	0.000544	0.000544	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ADA—autistic disorder	0.000522	0.000522	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—APC—autistic disorder	0.000521	0.000521	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PIK3CG—autistic disorder	0.000521	0.000521	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—autistic disorder	0.000516	0.000516	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—EGF—autistic disorder	0.000515	0.000515	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—POMC—autistic disorder	0.000496	0.000496	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—autistic disorder	0.000494	0.000494	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—IGF1—autistic disorder	0.000477	0.000477	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—RORA—autistic disorder	0.000476	0.000476	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—MAPK1—autistic disorder	0.000474	0.000474	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—SERPINE1—autistic disorder	0.000453	0.000453	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—MAOB—autistic disorder	0.000446	0.000446	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—APOE—autistic disorder	0.000425	0.000425	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—TPH2—autistic disorder	0.000415	0.000415	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—DPYD—autistic disorder	0.000408	0.000408	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	0.000383	0.000383	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—HRAS—autistic disorder	0.000381	0.000381	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CACNA1C—autistic disorder	0.000379	0.000379	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—IL2—autistic disorder	0.000366	0.000366	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—POMC—autistic disorder	0.000365	0.000365	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—IL6—autistic disorder	0.000365	0.000365	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—DHFR—autistic disorder	0.000345	0.000345	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PTEN—autistic disorder	0.000345	0.000345	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	0.000291	0.000291	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—MAPK1—autistic disorder	0.00028	0.00028	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CYP19A1—autistic disorder	0.00027	0.00027	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	0.000254	0.000254	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—COMT—autistic disorder	0.000251	0.000251	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GSTP1—autistic disorder	0.00025	0.00025	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—MAOA—autistic disorder	0.00025	0.00025	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CAT—autistic disorder	0.000243	0.000243	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GSTM1—autistic disorder	0.00023	0.00023	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PLA2G4A—autistic disorder	0.00023	0.00023	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—HRAS—autistic disorder	0.000225	0.000225	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GPX1—autistic disorder	0.00022	0.00022	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—IL6—autistic disorder	0.000215	0.000215	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—MTHFR—autistic disorder	0.000203	0.000203	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—APOE—autistic disorder	0.000189	0.000189	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PIK3CG—autistic disorder	0.000171	0.000171	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—POMC—autistic disorder	0.000162	0.000162	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PTGS2—autistic disorder	0.00013	0.00013	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PTEN—autistic disorder	0.000113	0.000113	CbGpPWpGaD
